Company Overview - A 60-year-old drug developer built a $4.4 billion biotech company [1] - The company focuses on treating 'Butterfly Skin Disease' (大疱性表皮松解症) [1]
Company Overview - A 60-year-old drug developer built a $4.4 billion biotech company [1] - The company focuses on treating 'Butterfly Skin Disease' (大疱性表皮松解症) [1]
Company Overview - A 60-year-old drug developer built a $4.4 billion biotech company [1] - The company focuses on treating 'Butterfly Skin Disease' (Epidermolysis Bullosa) [1]
